Trends in the management of childhood lead poisonings

J. F. Rosen, Morri E. Markowitz

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

It is unknown whether prompt medical management (with or without chelation therapy) and environmental intervention have beneficial effects other than stopping the progression towards symptomatic childhood lead poisoning. Stated differently, does prompt intervention have substantive beneficial effects or are untreated lead toxic children with blood lead values between 25-54 μg/dl irrevocably damaged by the time of their identification. We are carrying out a prospective treatment outcome study with CaNa2EDTA (when indicated) at our Center to hopefully answer this critical question, within the context of a multidisciplinary study. The results in 162 children indicate that environmental and medical management produce significant reductions in blood lead, erythrocyte protoporphyrin and the lead diuresis during a CaNa2EDTA provocative test. However, CaNa2EDTA treatment failed to decrease bone lead values dramatically, measured by L-line x-ray fluorescence, six months after enrollment in any patient group (treated or untreated with CaNa2EDTA). The uses of L-line x-ray fluorescence in this study and K-line x-ray fluorescence measurements of lead in bone in other reported studies open a wide time window of months to years of lead exposure, compared to 30-45 days, the time of exposure captured by blood lead levels. As with all chelating agents, DMSA should be administered to children in lead free housing, after this drug's toxicity is more widely assessed. The potential capability of DMSA to ameliorate neurobehavioral deficits produced by lead must be systematically assessed and compared with CaNa2EDTA in a randomized, controlled study before the use (s) of either drug become uncritically accepted as the treatment of choice for childhood lead poisoning, in addition to full abatement.

Original languageEnglish (US)
Pages (from-to)211-218
Number of pages8
JournalNeuroToxicology
Volume14
Issue number2-3
StatePublished - 1993

Fingerprint

Industrial poisons
Lead Poisoning
Succimer
Fluorescence
X-Rays
Blood
X rays
Chelation Therapy
Bone
Bone and Bones
Poisons
Diuresis
Chelating Agents
Drug-Related Side Effects and Adverse Reactions
Chelation
Pharmaceutical Preparations
Erythrocytes
Toxicity
Outcome Assessment (Health Care)
Lead

Keywords

  • Blood Lead
  • Bone Lead
  • CaNaEDTA
  • DMSA
  • L-Line X-Ray Fluorescence

ASJC Scopus subject areas

  • Neuroscience(all)
  • Cellular and Molecular Neuroscience
  • Toxicology

Cite this

Trends in the management of childhood lead poisonings. / Rosen, J. F.; Markowitz, Morri E.

In: NeuroToxicology, Vol. 14, No. 2-3, 1993, p. 211-218.

Research output: Contribution to journalArticle

Rosen, J. F. ; Markowitz, Morri E. / Trends in the management of childhood lead poisonings. In: NeuroToxicology. 1993 ; Vol. 14, No. 2-3. pp. 211-218.
@article{0f7b7de661964679a3e6c0f63c56c5f9,
title = "Trends in the management of childhood lead poisonings",
abstract = "It is unknown whether prompt medical management (with or without chelation therapy) and environmental intervention have beneficial effects other than stopping the progression towards symptomatic childhood lead poisoning. Stated differently, does prompt intervention have substantive beneficial effects or are untreated lead toxic children with blood lead values between 25-54 μg/dl irrevocably damaged by the time of their identification. We are carrying out a prospective treatment outcome study with CaNa2EDTA (when indicated) at our Center to hopefully answer this critical question, within the context of a multidisciplinary study. The results in 162 children indicate that environmental and medical management produce significant reductions in blood lead, erythrocyte protoporphyrin and the lead diuresis during a CaNa2EDTA provocative test. However, CaNa2EDTA treatment failed to decrease bone lead values dramatically, measured by L-line x-ray fluorescence, six months after enrollment in any patient group (treated or untreated with CaNa2EDTA). The uses of L-line x-ray fluorescence in this study and K-line x-ray fluorescence measurements of lead in bone in other reported studies open a wide time window of months to years of lead exposure, compared to 30-45 days, the time of exposure captured by blood lead levels. As with all chelating agents, DMSA should be administered to children in lead free housing, after this drug's toxicity is more widely assessed. The potential capability of DMSA to ameliorate neurobehavioral deficits produced by lead must be systematically assessed and compared with CaNa2EDTA in a randomized, controlled study before the use (s) of either drug become uncritically accepted as the treatment of choice for childhood lead poisoning, in addition to full abatement.",
keywords = "Blood Lead, Bone Lead, CaNaEDTA, DMSA, L-Line X-Ray Fluorescence",
author = "Rosen, {J. F.} and Markowitz, {Morri E.}",
year = "1993",
language = "English (US)",
volume = "14",
pages = "211--218",
journal = "NeuroToxicology",
issn = "0161-813X",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Trends in the management of childhood lead poisonings

AU - Rosen, J. F.

AU - Markowitz, Morri E.

PY - 1993

Y1 - 1993

N2 - It is unknown whether prompt medical management (with or without chelation therapy) and environmental intervention have beneficial effects other than stopping the progression towards symptomatic childhood lead poisoning. Stated differently, does prompt intervention have substantive beneficial effects or are untreated lead toxic children with blood lead values between 25-54 μg/dl irrevocably damaged by the time of their identification. We are carrying out a prospective treatment outcome study with CaNa2EDTA (when indicated) at our Center to hopefully answer this critical question, within the context of a multidisciplinary study. The results in 162 children indicate that environmental and medical management produce significant reductions in blood lead, erythrocyte protoporphyrin and the lead diuresis during a CaNa2EDTA provocative test. However, CaNa2EDTA treatment failed to decrease bone lead values dramatically, measured by L-line x-ray fluorescence, six months after enrollment in any patient group (treated or untreated with CaNa2EDTA). The uses of L-line x-ray fluorescence in this study and K-line x-ray fluorescence measurements of lead in bone in other reported studies open a wide time window of months to years of lead exposure, compared to 30-45 days, the time of exposure captured by blood lead levels. As with all chelating agents, DMSA should be administered to children in lead free housing, after this drug's toxicity is more widely assessed. The potential capability of DMSA to ameliorate neurobehavioral deficits produced by lead must be systematically assessed and compared with CaNa2EDTA in a randomized, controlled study before the use (s) of either drug become uncritically accepted as the treatment of choice for childhood lead poisoning, in addition to full abatement.

AB - It is unknown whether prompt medical management (with or without chelation therapy) and environmental intervention have beneficial effects other than stopping the progression towards symptomatic childhood lead poisoning. Stated differently, does prompt intervention have substantive beneficial effects or are untreated lead toxic children with blood lead values between 25-54 μg/dl irrevocably damaged by the time of their identification. We are carrying out a prospective treatment outcome study with CaNa2EDTA (when indicated) at our Center to hopefully answer this critical question, within the context of a multidisciplinary study. The results in 162 children indicate that environmental and medical management produce significant reductions in blood lead, erythrocyte protoporphyrin and the lead diuresis during a CaNa2EDTA provocative test. However, CaNa2EDTA treatment failed to decrease bone lead values dramatically, measured by L-line x-ray fluorescence, six months after enrollment in any patient group (treated or untreated with CaNa2EDTA). The uses of L-line x-ray fluorescence in this study and K-line x-ray fluorescence measurements of lead in bone in other reported studies open a wide time window of months to years of lead exposure, compared to 30-45 days, the time of exposure captured by blood lead levels. As with all chelating agents, DMSA should be administered to children in lead free housing, after this drug's toxicity is more widely assessed. The potential capability of DMSA to ameliorate neurobehavioral deficits produced by lead must be systematically assessed and compared with CaNa2EDTA in a randomized, controlled study before the use (s) of either drug become uncritically accepted as the treatment of choice for childhood lead poisoning, in addition to full abatement.

KW - Blood Lead

KW - Bone Lead

KW - CaNaEDTA

KW - DMSA

KW - L-Line X-Ray Fluorescence

UR - http://www.scopus.com/inward/record.url?scp=0027384649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027384649&partnerID=8YFLogxK

M3 - Article

C2 - 8247394

AN - SCOPUS:0027384649

VL - 14

SP - 211

EP - 218

JO - NeuroToxicology

JF - NeuroToxicology

SN - 0161-813X

IS - 2-3

ER -